NAA40 Antikörper (C-Term)
Kurzübersicht für NAA40 Antikörper (C-Term) (ABIN500326)
Target
Alle NAA40 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, mouse
-
Aufreinigung
- Peptide affinity chromatography
-
Immunogen
- NAT11 antibody was raised against a 15 amino acid peptide near the carboxy terminus of human NAT11.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
ELISA. Western blot: 1 - 2 μg/mL. Immunohistochemistry on paraffin sections.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 1.0 mg/mL
-
Buffer
- PBS containing 0.02 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store the antibody (in aliquots) at -20 °C.
-
-
- NAA40 (N(alpha)-Acetyltransferase 40 (NAA40))
-
Andere Bezeichnung
- NAT11
-
Hintergrund
- N-terminal acetylation is one of the most common protein modifications in eukaryotes, occurring on approximately 57 % and 84 % on yeast and human proteins respectively. There are several N-terminal acetylating enzyme complexes (NatA - NatE). Unlike the other complexes, NatD is composed of a single protein, NAT11, and has recently been described to acetylate the Serine N-termini of histones H2A and H4 in yeast. The role these modifications play is unknown, yeast that do not express NAT11 grow at normal rates and have no observable phenotypes. The role of the human homolog is likewise unknown.Synonyms: N-acetyltransferase 11
-
Gen-ID
- 79829
-
NCBI Accession
- NP_079047
-
UniProt
- Q86UY6
Target
-